Pfizer CEO awarded $1M Genesis Prize for developing COVID vaccine
Albert Bourla, chairman and CEO of Pfizer, has been awarded the 2022 Genesis Prize for his “leadership, determination and especially for his willingness to assume great risks” in developing a coronavirus vaccine in record time. The Genesis Foundation recognises individuals for their contribution to humanity and commitment to Jewish values.
View the full story here: https://www.aljazeera.com/economy/2022/1/19/pfizer-ceo-awarded-1m-genesis-prize-for-developing-covid-vaccine